| scholarly article | Q13442814 |
| P2093 | author name string | Mary J Burgess | |
| John D Zeuli | |||
| Mary J Kasten | |||
| P2860 | cites work | Estimated HIV incidence in the United States, 2006-2009 | Q21135528 |
| Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement | Q22241128 | ||
| American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults | Q24620909 | ||
| Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
| Cardiovascular risk and dyslipidemia management in HIV-infected patients | Q26851934 | ||
| The rising challenge of non-AIDS-defining cancers in HIV-infected patients | Q26861496 | ||
| CD4+ count-guided interruption of antiretroviral treatment | Q29619489 | ||
| Prognosis in HIV-1 infection predicted by the quantity of virus in plasma | Q29619980 | ||
| Psychological Impacts among Older and Younger People Living with HIV/AIDS in Nanning, China | Q34009280 | ||
| Virologic and immunologic response to HAART, by age and regimen class | Q34137148 | ||
| A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity | Q34175208 | ||
| Premature age-related comorbidities among HIV-infected persons compared with the general population. | Q51000618 | ||
| CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. | Q53455078 | ||
| Longitudinal studies on the rate of decline in renal function with age. | Q55061206 | ||
| The incidence of adverse drug events in two large academic long-term care facilities | Q58070800 | ||
| Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata | Q58415447 | ||
| Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up | Q61766737 | ||
| Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008 | Q64125801 | ||
| Antiretroviral adherence and use of alternative therapies among older HIV-infected adults | Q74326384 | ||
| Effectiveness of interventions to improve patient compliance: a meta-analysis | Q77108008 | ||
| HIV infection: treatment outcomes in older and younger adults | Q78024450 | ||
| Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study | Q79299687 | ||
| No association of abacavir use with myocardial infarction: findings of an FDA meta-analysis | Q34296639 | ||
| Liver Disease in the HIV–Infected Individual | Q34380326 | ||
| The new invincibles: HIV screening among older adults in the U.S. | Q34405393 | ||
| Liver function and phase I drug metabolism in the elderly: a paradox | Q34481252 | ||
| CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? | Q34499000 | ||
| Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | Q34567572 | ||
| Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature | Q35063693 | ||
| Incidence and preventability of adverse drug events among older persons in the ambulatory setting | Q35080020 | ||
| What do we know about older adults and HIV? A review of social and behavioral literature. | Q35420192 | ||
| Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study | Q36116238 | ||
| Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies | Q36154208 | ||
| Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care | Q36492436 | ||
| Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities | Q36641870 | ||
| A study of sexuality and health among older adults in the United States | Q36717888 | ||
| HIV-1 infection and the kidney: an evolving challenge in HIV medicine | Q36931067 | ||
| Management of human immunodeficiency virus infection in advanced age. | Q36933984 | ||
| Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. | Q37409009 | ||
| Altered pharmacodynamics in the elderly | Q37919209 | ||
| Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus | Q38008447 | ||
| Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection | Q38171753 | ||
| Aging and HIV infection: a comparison between older HIV-infected persons and the general population | Q39937080 | ||
| Assessment and predictors of antiretroviral adherence in older HIV-infected patients. | Q40575695 | ||
| Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy | Q40782728 | ||
| Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database | Q42646424 | ||
| Response to combination antiretroviral therapy: variation by age. | Q44396687 | ||
| Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America | Q45382453 | ||
| Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians' beliefs, practices, and knowledge. | Q45762881 | ||
| AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys | Q46130086 | ||
| Older age and the response to and tolerability of antiretroviral therapy | Q46177165 | ||
| Antiretroviral-drug resistance among patients recently infected with HIV. | Q46277555 | ||
| Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects | Q46758196 | ||
| Vital signs: HIV prevention through care and treatment--United States. | Q46910400 | ||
| Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection | Q48424453 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 251-64 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | HIV/AIDS – Research and Palliative Care | Q5629906 |
| P1476 | title | Management of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapy | |
| P478 | volume | 7 |
| Q56991795 | Achieving the fourth 90: healthy aging for people living with HIV |
| Q56925208 | Behavioral and cognitive interventions to improve treatment adherence and access to HIV care among older adults in sub-Saharan Africa: an updated systematic review |
| Q58700561 | Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection |
| Q89746364 | Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria |
| Q64994473 | Ethnicity, Stigma and Adherence to Antiretroviral Therapy (ART) among People Living with HIV/AIDS in Guangxi, China. |
| Q51762629 | Impact of Alcohol on HIV Disease Pathogenesis, Comorbities and Aging: Integrating Preclinical and Clinical Findings. |
| Q92191438 | Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis |
| Q92953588 | Older HIV-infected adults. Complex patients (III): Polypharmacy |
| Q57403878 | PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics |
| Q47550002 | Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map. |
Search more.